Oscar Health (NYSE:OSCR) Shares Down 6.3%

Oscar Health, Inc. (NYSE:OSCR) shares traded down 6.3% during trading on Friday . The stock traded as low as $16.17 and last traded at $16.54. 824,741 shares changed hands during trading, a decline of 75% from the average session volume of 3,278,018 shares. The stock had previously closed at $17.65.

Analyst Ratings Changes

A number of equities research analysts have weighed in on OSCR shares. Raymond James initiated coverage on Oscar Health in a research report on Friday, March 22nd. They set an “outperform” rating and a $20.00 target price for the company. Piper Sandler assumed coverage on shares of Oscar Health in a research note on Wednesday. They issued an “overweight” rating and a $25.00 price objective for the company. Wells Fargo & Company raised their target price on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research report on Wednesday, June 12th. The Goldman Sachs Group increased their price objective on shares of Oscar Health from $16.00 to $21.00 and gave the company a “neutral” rating in a research note on Thursday, May 9th. Finally, Robert W. Baird assumed coverage on shares of Oscar Health in a research note on Thursday, May 30th. They issued an “outperform” rating and a $28.00 price objective for the company. Three analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $19.75.

Oscar Health Stock Performance

The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.10 and a current ratio of 1.10. The stock has a market cap of $3.75 billion, a PE ratio of -39.55 and a beta of 1.68. The firm has a fifty day moving average price of $19.49 and a 200 day moving average price of $15.37.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Tuesday, May 7th. The company reported $0.62 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.34. The company had revenue of $2.14 billion during the quarter, compared to analysts’ expectations of $1.99 billion. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The firm’s revenue was up 45.8% compared to the same quarter last year. During the same period last year, the business posted ($0.18) earnings per share. Research analysts forecast that Oscar Health, Inc. will post -0.05 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Oscar Health news, CAO Victoria Baltrus sold 7,674 shares of the firm’s stock in a transaction on Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $149,336.04. Following the completion of the transaction, the chief accounting officer now owns 127,754 shares of the company’s stock, valued at $2,486,092.84. The transaction was disclosed in a filing with the SEC, which is available at this link. In other news, CAO Victoria Baltrus sold 7,674 shares of the stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $149,336.04. Following the transaction, the chief accounting officer now directly owns 127,754 shares of the company’s stock, valued at $2,486,092.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Steven Wolin sold 18,607 shares of the firm’s stock in a transaction dated Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $362,092.22. Following the completion of the transaction, the chief operating officer now owns 65,316 shares of the company’s stock, valued at $1,271,049.36. The disclosure for this sale can be found here. Insiders sold 81,655 shares of company stock worth $1,589,006 in the last three months. Corporate insiders own 25.11% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the business. Vanguard Group Inc. grew its stake in shares of Oscar Health by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock worth $216,846,000 after purchasing an additional 337,850 shares during the period. Formation8 GP LLC purchased a new stake in shares of Oscar Health during the fourth quarter worth $47,480,000. Price T Rowe Associates Inc. MD lifted its stake in Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock worth $59,156,000 after purchasing an additional 2,409,160 shares in the last quarter. Dimensional Fund Advisors LP increased its position in Oscar Health by 14.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,162,935 shares of the company’s stock worth $28,942,000 after purchasing an additional 392,837 shares during the last quarter. Finally, Gilder Gagnon Howe & Co. LLC raised its position in Oscar Health by 21.0% in the fourth quarter. Gilder Gagnon Howe & Co. LLC now owns 2,830,947 shares of the company’s stock valued at $25,903,000 after purchasing an additional 491,861 shares during the period. Hedge funds and other institutional investors own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.